Company intelligence / Profile preview

Savvysherpa

Brooklyn Park, Minnesota, USpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Developed Level2, a real-time glucose monitoring-based diabetes management program aimed at improving type 2 diabetes outcomes and reducing costs. The product was further developed and launched commercially by UnitedHealth Group after acquisition.

Therapeutic areas: Endocrinology
Industry: Digital Health Medical Devices

Partnerships

Partnered with various healthcare organizations to develop/test new products prior to acquisition; specifics not disclosed

Beyond the preview

Go deeper on Savvysherpa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Savvysherpa.

Explore the full profile